MAPT and Alzheimer disease: Other neurochemical changes associated with both AD and epilepsy include GABAergic (35) and glutamatergic alterations (36), Aβ and tau protein deposition (37), neuroinflammation (10), and damage to the noradrenergic nervous system in the locus coeruleus (38) (Figure 1).